Angiogenesis in pterygium: Morphometric and immunohistochemical study

Objective. To evaluate the role of angiogenesis in the pathogenesis of pterygium by comparing the expression of von-Willebrand factor (vWF) and vascular endothelial growth factor (VEGF) in pterygium, and in normal superior bulbar conjunctiva. Methods. 23 human samples from pterygium and the superior bulbar conjunctiva were stained using rabbit anti-vWF and anti-VEGF antibodies. The density of vWF and VEGF positive vessels, VEGF staining intensity and the number of VEGF positive stromal, epithelial and vascular endothelial cells were evaluated. Results. Pterygium specimens had higher average vWF and VEGF positive microvascular counts per high power field (P = 0.0012), higher average VEGF staining intensity scores in epithelial, stromal and endothelial cells (p < 0.0001) and higher VEGF positive cell counts (P < 0.0001) than normal conjuctiva. Conclusions. Over-expression of VEGF in pterygium tissue, together with the abundance of vWF-stained new vessels, may support previous suggestions that angiogenesis may play a role in the formation of pterygium.

[1]  Jun-Sub Choi,et al.  Expression of Vascular Endothelial Growth Factor and Inducible Nitric Oxide Synthase in Pterygia , 2001, Cornea.

[2]  C. Humpel,et al.  Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas. , 2000, Investigative ophthalmology & visual science.

[3]  D. Wakefield,et al.  Expression of MMPs and TIMPs in human pterygia and cultured pterygium epithelial cells. , 2000, Investigative ophthalmology & visual science.

[4]  R. Alon,et al.  The chemokine SDF-1 stimulates integrin-mediated arrest of CD34(+) cells on vascular endothelium under shear flow. , 1999, The Journal of clinical investigation.

[5]  D. Wakefield,et al.  The pathogenesis of pterygia. , 1999, Current opinion in ophthalmology.

[6]  Ivana K. Kim,et al.  Constitutive expression of VEGF, VEGFR-1, and VEGFR-2 in normal eyes. , 1999, Investigative ophthalmology & visual science.

[7]  J. K. Chen,et al.  Inhibition of vascular endothelial cell morphogenesis in cultures by limbal epithelial cells. , 1999, Investigative ophthalmology & visual science.

[8]  Y. Wen,et al.  Correlation of VEGF expression by leukocytes with the growth and regression of blood vessels in the rat cornea. , 1999, Investigative ophthalmology & visual science.

[9]  N. Ebihara,et al.  Mast cells in pterygium: number and phenotype. , 1999, Japanese journal of ophthalmology.

[10]  H. Suzuki,et al.  Effect of a topically applied neutralizing antibody against vascular endothelial growth factor on corneal allograft rejection of rat. , 1998, Transplantation.

[11]  A. Harris,et al.  Expression of VEGF in routinely fixed material using a new monoclonal , 1998, The Journal of pathology.

[12]  T. Amemiya,et al.  Growth factors in cultured pterygium fibroblasts: immunohistochemical and ELISA analysis , 1998, Graefe's Archive for Clinical and Experimental Ophthalmology.

[13]  W. Sekundo,et al.  Capillaries in the epithelium of pterygium , 1998, The British journal of ophthalmology.

[14]  B. Davidson,et al.  Angiogenesis in Uterine Cervical Intraepithelial Neoplasia and Squamous Cell Carcinoma: An Immunohistochemical Study , 1997, International Journal of Gynecological Pathology.

[15]  J. Rosenbaum,et al.  Immunolocalization of bFGF in Pterygia: Association with Mast Cells , 1997, Cornea.

[16]  E. Abel.  Clinical applications of research on angiogenesis , 1996 .

[17]  T. Terada,et al.  A morphometric and immunohistochemical study on angiogenesis of human metastatic carcinomas of the liver , 1996, Hepatology.

[18]  T. Amemiya,et al.  Immunohistochemical localization of basic fibroblast growth factor, platelet derived growth factor, transforming growth factor-β and tumor necrosis factor-α in the pterygium , 1996 .

[19]  J. Isola,et al.  Comparison of different immunohistochemical methods in the assessment of angiogenesis: lack of prognostic value in a group of 77 selected node-negative breast carcinomas. , 1995, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[20]  Bing Li,et al.  Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo , 1993, Nature.

[21]  D. Goeddel,et al.  Vascular endothelial growth factor is a secreted angiogenic mitogen. , 1989, Science.

[22]  Steuhl Kp.  Ultrastructure of the Conjunctival Epithelium , 1989 .

[23]  F. Hollows,et al.  Pterygium and ultraviolet radiation: a positive correlation. , 1984, The British journal of ophthalmology.

[24]  S. Horiguchi,et al.  Pterygium in welders. , 1984, The British journal of ophthalmology.

[25]  H. Taylor.  Aetiology of climatic droplet keratopathy and pterygium. , 1980, The British journal of ophthalmology.

[26]  Wong Ww,et al.  A hypothesis on the pathogenesis of pterygiums. , 1978 .

[27]  J. Malagelada,et al.  Increased expression of angiogenic factors in human colonic angiodysplasia , 1999, American Journal of Gastroenterology.

[28]  A. Adamis,et al.  Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization. , 1998, Investigative ophthalmology & visual science.

[29]  T. Amemiya,et al.  TNP-470 (a fungus-derived inhibitor of angiogenesis) reduces proliferation of cultured fibroblasts isolated from primary pterygia: a possible drug therapy for pterygia. , 1998, Current eye research.

[30]  G. V. van Setten.  Vascular endothelial growth factor (VEGF) in normal human corneal epithelium: detection and physiological importance. , 1997, Acta ophthalmologica Scandinavica.

[31]  K. Steuhl.  Ultrastructure of the conjunctival epithelium. , 1989, Developments in ophthalmology.

[32]  W. W. Wong.  A hypothesis on the pathogenesis of pterygiums. , 1978, Annals of Ophthalmology.

[33]  S. Theobald.  The Pathogenesis of Pterygium. , 1887, Transactions of the American Ophthalmological Society.